全球脊柱生物制剂市场 – 行业趋势及 2028 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Healthcare Global Spine Biologics Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球脊柱生物制剂市场 – 行业趋势及 2028 年预测

  • Healthcare
  • Upcoming Report
  • Mar 2021
  • Global
  • 350 页面
  • 桌子數： 60
  • 图号： 220
立即购买 立即购买

Global Spine Biologics Market

市场规模（十亿美元）

CAGR :  % Diagram

Diagram Forecast Period
 2022 –2028
Diagram Market Size (Base Year)
 USD MILLION
Request
Diagram Market Size (Forecast Year)
 USD 24.15 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • Arthrex
  • Cesca Therapeutics
  • DePuy Synthes Orthopaedic Seminar
  • Exactech
  • K2M

>全球脊柱生物制剂市场，按产品（骨同种异体移植、骨移植替代品、富血小板血浆、骨髓抽吸疗法）、手术类型（前路颈椎间盘切除和融合术 (ACDF)、经椎间孔腰椎椎间融合术 (TLIF)、前路腰椎椎间融合术 (ALIF)、侧路腰椎椎间融合术 (LLIF)）、最终用户（医院、脊柱外科中心、骨科诊所等）、国家（美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区）行业趋势和预测到 2028 年

脊柱生物制剂市场市场分析与洞察：全球脊柱生物制剂市场

预计脊柱生物制剂市场在 2021 年至 2028 年的预测期内将以 4.03% 的速度增长。Data Bridge Market Research 关于脊柱生物制剂市场的报告提供了有关预测期内预计会盛行的各种因素的分析和见解，同时提供了它们对市场增长的影响。全球脊柱疾病患病率的增加正在加速脊柱生物制剂市场的增长。

生物材料是指一种有助于改变周围环境并通过活跃的生物过程对环境产生影响的物质。这些影响可以通过增加细胞活性、分化和生长来体现。脊柱生物材料包括广泛用于骨融合手术、退行性椎间盘疾病和脊髓损伤的材料。

全球范围内退行性脊柱疾病病例的增加和治疗率的显著提高是推动脊柱生物制剂市场增长的主要因素。骨移植手术的技术进步、这些生物制剂在脊柱手术中的重要作用以及对微创手术的高需求加速了脊柱生物制剂市场的增长。生物材料在退行性椎间盘疾病、脊髓损伤和骨融合手术的治疗中的大量使用以及由于其快速愈合、术后时间最短和激活细胞扩增的能力而得到广泛采用，进一步影响了脊柱生物制剂市场。此外，老年人口的增长、对新开发的脊柱治疗技术的认识不断提高、研发活动和医疗保健支出的激增都对脊柱生物制剂市场产生了积极影响。此外，在 2021 年至 2028 年的预测期内，技术先进且具有成本效益的产品的开发为脊柱生物制剂市场参与者带来了盈利机会。   

另一方面，手术的高成本和不利的报销情况是阻碍脊柱生物制剂市场增长的因素。预计在 2021 年至 2028 年的预测期内，患者缺乏了解以及缺乏专业知识和专业知识将对脊柱生物制剂市场构成挑战。

本脊柱生物制剂市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关脊柱生物制剂市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。 

脊柱生物制剂市场范围和市场规模

脊柱生物制剂市场根据产品、手术类型和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。 

  • 根据产品，脊柱生物制剂市场分为骨同种异体移植、骨移植替代品、富血小板血浆和骨髓抽吸疗法。
  • 根据手术类型，脊柱生物制剂市场分为前路颈椎间盘切除和融合术 (ACDF)、经椎间孔腰椎椎间融合术 (TLIF)、前路腰椎椎间融合术 (ALIF)、侧腰椎椎间融合术 (LLIF) 等。
  • 根据最终用户，脊柱生物制剂市场分为医院、脊柱外科中心、骨科诊所和其他。

全球脊柱生物制剂市场国家级分析

对脊柱生物制剂市场进行了分析，并按国家、产品、手术类型和最终用户提供了市场规模洞察和趋势。      

脊柱生物制剂市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于经济增长稳定、脊柱疾病（如椎管狭窄、椎间盘相关问题和脊椎滑脱）患病率不断上升以及微创手术的广泛采用，北美在脊柱生物制剂市场占据主导地位。由于患者人数众多、基础设施和医疗设施改善、脊柱损伤患病率高、医疗支出激增以及外科医生和患者意识增强，预计亚太地区将在 2021-2028 年预测期内实现最快增长。

脊柱生物制剂市场报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。消费量、生产地点和产量、进出口分析、价格趋势分析、原材料成本、下游和上游价值链分析等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

脊柱生物制剂市场还为您提供每个国家/地区资本设备医疗保健支出增长、脊柱生物制剂市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对脊柱生物制剂市场的影响的详细市场分析。数据适用于 2011-2019 年的历史时期。

竞争格局和脊柱生物制剂市场份额分析

脊柱生物制剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对脊柱生物制剂市场的关注有关。

脊柱生物制剂市场报告中涉及的主要参与者包括 Arthrex, Inc.、Cesca Therapeutics Inc.、DePuy Synthes、Orthopaedic Seminar、Exactech, Inc.、K2M, Inc.、Lattice Biologics Ltd、Medtronic、NuTech Spine, Inc.、NuVasive Inc.、Orthofix Holdings, Inc.、Regen Lab USA LLC、RTI Surgical Holdings, Inc.、Stryker、Wright Medical Group NV、XTANT MEDICAL、Zimmer Biomet、Smith & Nephew、Dr PRP USA LLC 以及其他国内和全球参与者。市场份额数据分别针对全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美提供。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1. INTRODUCTION

       1.1. OVERVIEW OF THE SPINE BIOLOGICS MARKET
       1.2. MARKET SEGMENTATION & COVERAGE
                1.2.1. CURRENCY AND PRICING 
                1.2.2. LIMITATION
                1.2.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

       2.1. KEY TAKEAWAYS
       2.2. ARRIVING AT THE GLOBAL SPINE BIOLOGICS MARKET SIZE
                2.2.1. MARKET CRACKDOWN APPROACH 
                2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
                2.2.3. DATA TRIANGULATION
                2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
                2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
                2.2.6. PORTER’S FIVE FORCES MATRIX
       2.3. GLOBAL SPINE BIOLOGICS MARKET: RESEARCH SNAPSHOT
       2.4. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

       4.1. OVERVIEW
       4.2. GLOBAL SPINE BIOLOGICS MARKET: KEY PRIMARY INSIGHTS
       4.3. MARKET OVERVIEW
                4.3.1. DRIVERS
                 4.3.2. RESTRAINTS
                4.3.3. OPPURTUNITIES
                4.3.4. THREATS
       4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. SPINE BIOLOGICS MARKET, BY PRODUCT TYPE

       5.1. OVERVIEW
       5.2. BONE GROWTH SUBSTITUTES
                5.2.1. DEMINERALIZED BONE MATRIX (DBM)
                5.2.2. BONE MORPHOGENETIC PROTEINS (BMP)
                5.2.3. SYNTHETIC BONE GRAFTS
       5.3. BONE ALLOGRAFTS
       5.4. PLATELET RICH PLASMA (PRP)
       5.5. BONE MARROW ASPIRATE CONCENTRATE (BMAC)

6. SPINE BIOLOGICS MARKET, BY SURGERY TYPE

       6.1. OVERVIEW
       6.2. ANTERIOR CERVICAL DISECTOMY AND FUSION (ACDF)
       6.3. TRANSFORAMENAL LUMBAR INTERBODY FUSION (TLIF)
       6.4. ANTERIOR LUMBAR INTERBODY FUSION (ALIF)
       6.5. LATERAL LUMBAR INTERBODY FUSION (LLIF)
       6.6. OTHERS

7. SPINE BIOLOGICS MARKET, BY END USER

       7.1. OVERVIEW
       7.2. HOSPITALS
       7.3. SPINAL SURGERY CENTERS
       7.4. ORTHOPEDIC CLINICS
       7.5. OTHERS

8. SPINE BIOLOGICS MARKET, BY GEOGRAPHY

       8.1. COUNTRYWISE SPINE BIOLOGICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
                8.1.1. NORTH AMERICA
                              8.1.1.1. U.S.
                              8.1.1.2. CANADA
                              8.1.1.3. MEXICO
                8.1.2. EUROPE
                              8.1.2.1. GERMANY
                              8.1.2.2. FRANCE
                              8.1.2.3. U.K.
                              8.1.2.4. ITALY
                              8.1.2.5. SPAIN
                              8.1.2.6. RUSSIA
                              8.1.2.7. TURKEY
                              8.1.2.8. BELGIUM
                              8.1.2.9. NETHERLANDS
                              8.1.2.10. SWITZERLAND
                              8.1.2.11. REST OF EUROPE
                8.1.3. ASIA-PACIFIC (APAC)
                              8.1.3.1. JAPAN
                              8.1.3.2. CHINA
                              8.1.3.3. SOUTH KOREA
                              8.1.3.4. INDIA
                              8.1.3.5. AUSTRALIA
                              8.1.3.6. SINGAPORE
                              8.1.3.7. THAILAND
                              8.1.3.8. MALAYSIA
                              8.1.3.9. INDONESIA
                              8.1.3.10. PHILIPPINES
                              8.1.3.11. REST OF APAC
                8.1.4. LATIN AMERICA
                              8.1.4.1. BRAZIL
                              8.1.4.2. REST OF LATIN AMERICA
                8.1.5. MIDDLE EAST AND AFRICA
                              8.1.5.1. SOUTH AFRICA
                              8.1.5.2. REST OF MIDDLE EAST AND AFRICA
       8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

9. SPINE BIOLOGICS MARKET: COMPETITIVE LANDSCAPE

       9.1. GLOBAL SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
       9.2. U.S. SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
       9.3. EUROPE SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
       9.4. APAC SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
       9.5. SOUTH AMERICA SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
       9.6. MIDDLE EAST AND AFRICA  SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS
       9.7. MERGERS & ACQUISITIONS
       9.8. NEW PRODUCT DEVELOPMENT & APPROVALS
       9.9. EXPANSIONS
       9.10. REGULATORY CHANGES
       9.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

10. SPINE BIOLOGICS MARKET, COMPANY PROFILES

       10.1. APPLIED BIOLOGICS
                         10.1.1. OVERVIEW
                         10.1.2. SWOT ANALYSIS
                         10.1.3. PRODUCT PORTFOLIO
                         10.1.4. REVENUE ANALYSIS
                         10.1.5. ANALYSTS VIEW
       10.2. ARTHREX, INC.
                         10.2.1. OVERVIEW
                         10.2.2. SWOT ANALYSIS
                         10.2.3. PRODUCT PORTFOLIO
                         10.2.4. REVENUE ANALYSIS
                         10.2.5. ANALYSTS VIEW
       10.3. CESCA THERAPEUTICS
                         10.3.1. OVERVIEW
                         10.3.2. SWOT ANALYSIS
                         10.3.3. PRODUCT PORTFOLIO
                         10.3.4. REVENUE ANALYSIS
                         10.3.5. ANALYST VIEW
       10.4. DEPUY SYNTHES
                         10.4.1. OVERVIEW
                         10.4.2. SWOT ANALYSIS
                         10.4.3. PRODUCT PORTFOLIO
                         10.4.4. REVENUE ANALYSIS
                         10.4.5. ANALYSTS VIEW
       10.5. DMP SPINE
                         10.5.1. OVERVIEW
                         10.5.2. SWOT ANALYSIS
                         10.5.3. PRODUCT PORTFOLIO
                         10.5.4. REVENUE ANALYSIS
                         10.5.5. ANALYSTS VIEW
       10.6. DR. PRP AMERICA LLC.
                         10.6.1. OVERVIEW
                         10.6.2. SWOT ANALYSIS
                         10.6.3. PRODUCT PORTFOLIO
                         10.6.4. REVENUE ANALYSIS
                         10.6.5. ANALYSTS VIEW
       10.7. EXACTECH, INC.
                         10.7.1. OVERVIEW
                         10.7.2. SWOT ANALYSIS
                         10.7.3. PRODUCT PORTFOLIO
                         10.7.4. REVENUE ANALYSIS
                         10.7.5. ANALYSTS VIEW
       10.8. K2M, INC.
                         10.8.1. OVERVIEW
                         10.8.2. SWOT ANALYSIS
                         10.8.3. PRODUCT PORTFOLIO
                         10.8.4. REVENUE ANALYSIS
                         10.1.5. ANALYSTS VIEW
       10.9. LATTICE BIOLOGICS
                         10.9.1. OVERVIEW
                         10.9.2. SWOT ANALYSIS
                         10.9.3. PRODUCT PORTFOLIO
                         10.9.4. REVENUE ANALYSIS
                         10.9.5. ANALYSTS VIEW
       10.10. MEDTRONIC
                         10.10.1. OVERVIEW
                         10.10.2. SWOT ANALYSIS
                         10.10.3. PRODUCT PORTFOLIO
                         10.10.4. REVENUE ANALYSIS
                         10.10.5. ANALYSTS VIEW
       10.11. NUVASIVE, INC.
                         10.11.1. OVERVIEW
                         10.11.2. SWOT ANALYSIS
                         10.11.3. PRODUCT PORTFOLIO
                         10.11.4. REVENUE ANALYSIS
                         10.11.5. ANALYSTS VIEW
       10.12. ORTHOFIX HOLDINGS, INC.
                         10.12.1. OVERVIEW
                         10.12.2. SWOT ANALYSIS
                         10.12.3. PRODUCT PORTFOLIO
                         10.12.4. REVENUE ANALYSIS
                         10.12.5. ANALYSTS VIEW
       10.13. REGENLAB S.A.
                         10.13.1. OVERVIEW
                         10.13.2. SWOT ANALYSIS
                         10.13.3. PRODUCT PORTFOLIO
                         10.13.4. REVENUE ANALYSIS
                         10.13.5. ANALYSTS VIEW
       10.14. RTI SURGICAL
                         10.14.1. OVERVIEW
                         10.14.2. SWOT ANALYSIS
                         10.14.3. PRODUCT PORTFOLIO
                         10.14.4. REVENUE ANALYSIS
                         10.14.5. ANALYSTS VIEW
       10.15. STRYKER CORPORATION
                         10.15.1. OVERVIEW
                         10.15.2. SWOT ANALYSIS
                         10.15.3. PRODUCT PORTFOLIO
                         10.15.4. REVENUE ANALYSIS
                         10.15.5. ANALYSTS VIEW
       10.16. WRIGHT MEDICAL
                         10.16.1. OVERVIEW
                         10.16.2. SWOT ANALYSIS
                         10.16.3. PRODUCT PORTFOLIO
                         10.16.4. REVENUE ANALYSIS
                         10.16.5. ANALYSTS VIEW
       10.17. X-SPINE SYSTEMS
                         10.17.1. OVERVIEW
                         10.17.2. SWOT ANALYSIS
                         10.17.3. PRODUCT PORTFOLIO
                         10.17.4. REVENUE ANALYSIS
                         10.17.5. ANALYSTS VIEW
       10.18. ZIMMER BIOMET
                         10.18.1. OVERVIEW
                         10.18.2. SWOT ANALYSIS
                         10.18.3. PRODUCT PORTFOLIO
                         10.18.4. REVENUE ANALYSIS
                         10.18.5. ANALYSTS VIEW

11. APPENDIX

12. ABOUT DATA BRIDGE MARKET RESEARCH

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Product (Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy), Surgery Type (Anterior Cervical Discectomy and Fusion (ACDF), Transforamenal Lumbar Interbody Fusion (TLIF), Anterior Lumbar Interbody Fusion (ALIF), Lateral Lumbar Interbody Fusion (LLIF)), End-User (Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028 .
The Global Spine Biologics Market size was valued at USD 0.00 USD Billion in 2021.
The Global Spine Biologics Market is projected to grow at a CAGR of 4.03% during the forecast period of 2022 to 2028.
The major players operating in the market include Arthrex , Cesca Therapeutics , DePuy Synthes Orthopaedic Seminar, Exactech , K2M , Lattice Biologics Ltd, Medtronic, NuTech Spine , NuVasive , Orthofix Holdings , Regen Lab USA LLC, RTI Surgical Holdings , Stryker, Wright Medical Group N.V., XTANT MEDICAL, Zimmer Biomet, Smith & Nephew, Dr PRP USA LLC,.

浏览相关页面

Banner